| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 10 Feb 2021 |  Dividend | ₹ 5.50 /share | 09 Feb 2021 | 564.35 | 623.60 |
| 25 Aug 2021 | Dividend | ₹ 2.00 /share | 23 Aug 2021 | 703.80 | 771.35 |
| 10 Feb 2022 | Dividend | ₹ 7.00 /share | 09 Feb 2022 | 827.35 | 886.45 |
| 22 Aug 2022 | Dividend | ₹ 3.00 /share | 19 Aug 2022 | 903.90 | 901.35 |
| 08 Feb 2023 | Dividend | ₹ 7.50 /share | 08 Feb 2023 | 1,050.90 | 1,005.65 |
| 28 Jul 2023 | Dividend | ₹ 4.00 /share | 28 Jul 2023 | 945.00 | 1,134.95 |
| 09 Feb 2024 | Dividend | ₹ 8.50 /share | 09 Feb 2024 | 1,371.60 | 1,500.25 |
| 12 Jul 2024 | Dividend | ₹ 5.00 /share | 12 Jul 2024 | 1,541.15 | 1,583.25 |
| 05 Aug 2024 |  Annual General Meeting | NA | 05 Aug 2024 | 1,520.65 | 1,731.65 |
| 28 Oct 2024 |  Quarterly Result Announcement | NA | 28 Oct 2024 | 1,916.85 | 1,860.40 |
| 21 Jan 2025 |  Extraordinary General Meeting | NA | 21 Jan 2025 | 1,806.20 | 1,778.25 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 1,756.85 | 1,739.10 |
| 06 Feb 2025 | Dividend | ₹ 10.50 /share | 06 Feb 2025 | 1,739.10 | 1,753.40 |
| 22 May 2025 | Quarterly Result Announcement | NA | 22 May 2025 | 1,744.85 | 1,731.60 |
| 07 Jul 2025 | Dividend | ₹ 5.50 /share | 07 Jul 2025 | 1,731.60 | 1,676.65 |
| 31 Jul 2025 | Annual General Meeting | NA | 31 Jul 2025 | 1,731.60 | 1,734.95 |
| 31 Jul 2025 | Quarterly Result Announcement | NA | 31 Jul 2025 | 1,663.15 | 1,734.95 |
| 05 Nov 2025 | Quarterly Result Announcement | NA | 05 Nov 2025 | 1,668.50 | 1,690.00 |
| 31 Jan 2026 | Quarterly Result Announcement | NA | 31 Jan 2026 | 1,673.55 | 1,595.00 |
| 05 Feb 2026 | Dividend | ₹ 11.00 /share | 05 Feb 2026 | 1,595.00 | 1,704.00 |
| 22 May 2026 | Quarterly Result Announcement | NA | 22 May 2026 | 1,847.90 | 1,891.15 |
| 07 Jul 2026 | Dividend | ₹ 5.00 /share | 07 Jul 2026 | 1,891.15 | 1,913.05 |
| 31 Jul 2026 | Annual General Meeting | NA | 31 Jul 2026 | 1,786.40 | 2,000.75 |
| 31 Jul 2026 | Quarterly Result Announcement | NA | 31 Jul 2026 | 1,938.70 | 2,000.75 |
Sun Pharmaceutical
1,903.00
-13.00
(-0.68%)
Market Cap
4,56,593.44 Cr
PE Ratio
37.70
Volume
5,56,201.00
Day High - Low
1,917.30 - 1,896.80
52W High-Low
2,046.90 - 1,548.00
Key Fundamentals
Market Cap
4,56,593.44 Cr
EPS
47.80
PE Ratio
37.70
PB Ratio
5.47
Book Value
348.31
EBITDA
19,703.10
Dividend Yield
0.84 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
13.79
Debt to Equity
0.04
Actual
Company News
View All News
Sun Pharma to meet analysts and investors in September22 hrs ago
Sun Pharmaceutical Industries has scheduled meetings with analysts and investors on September 10, 16, and 17.
Sun Pharma joins White House ceremony to announce MFN pricing for Medicaid programs. The agreement delays Section 232 tariffs on innovative drugs for over two years.
Sun Pharmaceutical Industries Limited has issued a postal ballot notice to reclassify three family members from the promoter group to the public category. The move, approved by the Board in May 2026, aims to align shareholding classification with the applicants' lack of management involvement.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,903.00 | #1 4,56,593.44 | #6 37.70 | #1 61,673.90 | #7 12.69 | #1 11,565 | #4 26.53 | 47.94 | |
9,143.50 | 2,42,731.20 | 83.91 | 11,067.00 | 13.95 | 2,568 | 65.50 | 71.41 | |
4,835.50 | 1,83,926.88 | 86.89 | 13,886.20 | 20.34 | 2,138 | 3.28 | 47.59 | |
1,125.90 | 1,13,291.88 | 24.65 | 27,657.90 | 17.64 | 5,026 | -34.90 | 50.50 | |
1,380.20 | 1,11,498.81 | 33.44 | 29,044.60 | 2.24 | 3,870 | -39.18 | 38.59 | |
1,842.80 | 99,484.77 | 92.77 | 6,867.80 | 22.01 | 890 | #1 123.93 | 59.60 | |
1,156.90 | 96,562.86 | 30.28 | 35,058.60 | 3.90 | 4,158 | -69.10 | 40.01 | |
2,108.00 | 96,384.62 | #1 17.59 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 28.16 | |
2,330.50 | 96,248.71 | 46.84 | 14,636.40 | 14.85 | 1,938 | 29.13 | 43.19 | |
1,657.60 | 95,374.64 | 25.23 | 34,145.20 | 5.56 | 3,503 | 25.21 | 52.26 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
12.69 %
Net Income Growth
5.32 %
Cash Flow Change
-11.75 %
ROE
-8.98 %
ROCE
-5.18 %
EBITDA Margin (Avg.)
1.46 %
Corporate Action
Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 51.21
ATR(14)
Volatile 36.41
STOCH(9,6)
Neutral 61.53
STOCH RSI(14)
Neutral 71.07
MACD(12,26)
Bullish 2.60
ADX(14)
Weak Trend 20.55
UO(9)
Bearish 54.93
ROC(12)
Uptrend And Accelerating 2.64
WillR(14)
Neutral -45.58
About Sun Pharmaceutical
Sun Pharmaceutical Industries Limited is a global specialty generic pharmaceutical company based in India. It manufactures and markets a wide range of pharmaceutical formulations including generics, branded generics, complex products, over-the-counter drugs, and active pharmaceutical ingredients. The company has a diverse portfolio covering multiple therapeutic areas and dosage forms. Sun...more
Website
Chairperson NameDilip S Shanghvi
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
